Klaveness Combination Carriers ASA (STO:KCCO)
72.10
+2.00 (2.85%)
At close: Aug 1, 2025
Intra-Cellular Therapies Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Source: S&P Global Market Intelligence. Standard template. Financial Sources.